Global Economic Cost of Cancer
On August 16, the American Cancer Society and LIVESTRONG® released the Global Economic Cost of Cancer report summary. This report, authored by Society researchers Rijo M. John, Ph.D., director of international tobacco control research, and Hana Ross, Ph.D., strategic director of international tobacco control research, is a first-of-its-kind study on the economic cost of all causes of death globally, including cancer and other noncommunicable diseases and communicable diseases. The report shows that cancer has the greatest economic impact from premature death and disability of all causes of death worldwide. The economic toll from cancer is nearly 20 percent higher than heart disease, the second leading cause of economic loss ($895 billion and $753 billion respectively). This figure does not include direct medical costs, which would further increase the overall economic impact of cancer. Dr. John Seffrin will deliver the report highlights during a dinner jointly hosted by the American Cancer Society and LIVESTRONG at the 2010 UICC World Cancer Congress in Shenzhen, China.
DOWNLOAD The Global Economic Costs of Cancer report summary. [PDF version, 408 KB]